CDEK
← All drugs Report issue

toralizumab

mAbexperimental

Clinical trial activity

0 trials · 0 clinical orgs · 0 marketing orgs

Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0

Mechanism of action

  • CD40 ligandINHIBITOR

    CD40LG inhibitor

    Binds to CD154, block CD154 binding to CD40 and inhibit T cell-dependent B cell differentiation, The latter activity is independent of FcR binding.

Chemistry & pharmacology

Chirality
Single Stereoisomer
Inorganic
No
Polymer
No
Multi-specific
No

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • anti-cd154
  • anti-cd40l
  • anti-gp39
  • e-6040
  • e-6040
  • idec-131
  • idec-131
  • monoclonal antibody idec131
  • toralizumab